Delivery Order SPE2DB25D3110-SPE2DB25FTCEA

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml, with a ceiling value of $5,825.04. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 3, 2023. This contract is not designated as a set-aside, indicating open competition....
The federal contract award described is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen, with a ceiling value of $2,902.80. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 27, 2022. The contract is not designated as a...
This federal contract award is for the supply of the medication Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,487.33 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is June 22, 2023. The contract is not designated with a set-aside....
The federal contract award is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml, with a ceiling value of $1,167.48. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, and has an ultimate completion date of November 13, 2024. The contract is not designated with a set-aside requirement,...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, valued at $7,026.30, was awarded on December 14, 2022, with a completion date of December 15, 2022. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (0.75 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $1,741.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and medical supply provider to the U.S. government. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml pharmaceutical products to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $6,868.96 and an ultimate completion date of October 10, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
The federal contract award is for the supply of Trulicity 0.75 mg/0.5 ml Pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with a ceiling value of $1,561.69 and a completion date of August 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is a child contract under a larger Indefinite Delivery...
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen with a ceiling value of $7,112.32. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The contract, valued at $11,411.35, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support...
  • SPE2DB25D3110
    Indefinite Delivery Contract
  • SPE2DB25D3110-SPE2DB25FTCEA
    Delivery Order

This federal contract award is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml, with a ceiling value of $1,617.33. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of January 3, 2025.

Generated 4/6/25, 12:47 AM